Percutaneous transvenous closure of atrial septal defects (ASDs) has become feasible in
recent years, as later‐generation devices have largely overcome initial difficulties in device …

Aim: To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal
defects (ASD) with the Amplatzer septal occluder. Methods: 236 consecutive patients with a …

Surgical treatment of various septal defects has been long established. With the advances in
transcatheter therapy dilatation techniques for valvular stenosis and vascular obstruction …

Percutaneous closure of atrial septal defect (ASD) and patent foramen ovale (PFO) has
become increasingly utilized. The indications and results of percutaneous closure are …

We present three cases of multiple interatrial communications to illustrate the extended use
of the Amplatzer septal occluder and to highlight procedural techniques. The first case …

Amplatzer septal occluder (AGA Med. Co., USA) is a novel device for occlusion of atrial
septal defect. We present our experience of transcatheter closure of atrial septal defects …

Objetivo Evaluar los resultados a medio plazo del cierrepercutáneo de la comunicación
interauricular mediantedos nuevos dispositivos. Pacientes y métodos Bajo anestesia …

Introducción: El cierre percutáneo de la comunicación interauricular es una alternativa al
tratamiento quirúrgico. Objetivos: Comunicar los resultados del cierre percutáneo de la …

This article presents the unusual appearance of a “cobra” due to “acute bending” of the
proximal part and partial opening of the distal part of the left atrial disk of an Amplatzer …

ZABAL-CERDEIRA, Carlos et al. Percutaneous closure of atrial septal defects with the
Amplatzer® device: 15 years of experience. Arch. Cardiol. Méx.[online]. 2014, vol. 84, n. 4 …